U.S. Capital Markets Stock News

Facility expansion and index additions frame fresh look at Karman Holdings Karman Holdings (KRMN) is in focus after Karman Space & Defense committed to a $2.7 million expansion of its Horsham, Pennsylvania facility and the stock was added to several S&P small cap and composite indices. See our latest analysis for Karman Holdings. The expansion news and index additions arrive after a tough stretch for Karman Holdings, with the stock’s 90 day share price return down 44.16% and year to date...

Age limits, succession questions, and leadership health are suddenly front-page topics, and that conversation does not stop at politics. For investors, it goes straight to boardrooms, where succession planning and governance can influence how confidently markets view a company’s future. Strong governance does not remove risk, but it can help reduce surprise around leadership changes and policy shifts. This article looks at 3 stocks from our Corporate Governance Leaders screener that appear...

Federal Realty Investment Trust recently announced its 58th consecutive annual dividend increase, underscoring the REIT’s long-running commitment to returning cash to shareholders. This extended dividend growth streak reinforces Federal Realty’s reputation as a reliable income payer, which is especially important for investors focused on steady distributions from retail-focused real estate. Next, we’ll examine how this latest dividend increase influences Federal Realty’s investment...

In July 2026, Super Micro Computer announced new Kubernetes Edge AI appliances built with Red Hat OpenShift and Everpure’s Portworx data management platform, delivering a prevalidated, turnkey stack for running AI workloads at distributed edge locations. An interesting aspect of this collaboration is Portworx by Everpure’s software-defined storage, which aggregates local edge server capacity into a resilient, self-healing data platform that continues operating through network outages. Next,...

After a solid multi year run, Neurocrine Biosciences stock now screens as roughly fairly valued on market multiples, and the broader valuation checks point to a more balanced picture than a clear bargain or an obvious stretch. Neurocrine Biosciences has returned 73.4% over the past 5 years, which puts recent gains at the center of any valuation discussion today. Expectations around the durability of its cash generation from existing treatments can support the current price. Any setback in...

Akamai Technologies has been selected as a key security partner for World Wide Technology’s new AI Readiness Model for Operational Resilience, known as the ARMOR framework. The framework is described as the industry’s first holistic, vendor agnostic AI security model, positioning Akamai as a foundational security layer. Akamai will work alongside partners such as NVIDIA and World Wide Technology to help protect critical AI infrastructure and sensitive data. For investors tracking...

Arcos Dorados redemption of sustainability linked notes draws investor focus Arcos Dorados Holdings (ARCO) is set to redeem all of its 6.125% sustainability linked senior notes due 2029, a debt move that puts balance sheet structure and future financing choices in focus. See our latest analysis for Arcos Dorados Holdings. At a share price of $8.23, Arcos Dorados Holdings has seen its short term momentum soften, with the 90 day share price return down 13.37%, while the 1 year total shareholder...

With inflation normalizing unevenly across regions, interest rate expectations shifting and energy prices swinging on geopolitics, dependable income is back in focus for many portfolios. That is where the Dividend Powerhouses (3%+ Yield) screener comes in, targeting companies that currently offer yields above 5% and whose dividends are described as well covered, growing and stable. Rather than chasing short term stories, you are zeroing in on cash returns that are designed to show up...

Enovis (ENOV) recently announced the U.S. launch of CT-RevitL, a next-generation veterinary PBM laser therapy system from its Companion Animal Health business, highlighting the company’s push into non-drug therapies for animal care. See our latest analysis for Enovis. The recent CT-RevitL launch comes as Enovis shares trade at US$27.07, with a 30-day share price return of 23.21% and a 7-day share price return of 5.13%. The 1-year total shareholder return of 2.97% contrasts with a 3-year total...

Younger workers are rewriting the rules of work, trading corporate ladders for seasonal jobs, flexible gigs, and lifestyle-focused roles that often come with lower pay but cheaper living costs and more free time. That shift can reshape where money is earned, saved, and spent, especially on travel, experiences, and services tied to flexible living. This article looks at how that news-driven trend connects to the stock market and highlights 3 stocks from the Stocks Shaped by Shifts in Worker...

In July 2026, Chesapeake Utilities Corporation and its subsidiary Peninsula Pipeline Company announced the Florida Energy Pathway, a new 24-inch intrastate natural gas pipeline running from Palm Beach County to Miami-Dade County, backed by nearly 250,000 dekatherms per day of firm shipper commitments and an estimated US$1.20 billion project cost. The project’s planned 2030 in-service date, long-term investment-grade shipper contracts and intention to bring in partners for up to 49% ownership...

ANI Pharmaceuticals recently reported positive topline results from its Phase 4 SYNCHRONICITY trial of the fluocinolone acetonide intravitreal implant in U.S. patients with chronic non-infectious uveitis affecting the posterior segment, with both co-primary endpoints in visual acuity and central subfield thickness met at six months. The data add real-world support for ILUVIEN’s expanded indication in chronic NIU-PS, potentially reinforcing its role in retina specialists’ treatment decisions...

US small business financials sit at an interesting crossroads, with a modest rate hike expected, steady credit conditions, and consumers still spending. For investors, that mix can influence how regional banks and specialty lenders manage risk, grow their loan books, and support Main Street clients. This article looks at how the latest macro signals link back to companies in our US Small Business Financials screener and how that might affect their risk and opportunity profile. Ahead, you will...

Samsung’s decision to cut U.S. jobs and double down on its chip division is a clear reminder that capital can move quickly toward what management sees as its strongest profit engines. For investors, it raises the question of which semiconductor and chip stocks might benefit as resources shift toward AI-focused production and infrastructure, and which could face pressure as consumer electronics take a back seat. This article breaks down three stocks from our AI Semiconductor and Chip Makers...

PTC Therapeutics (PTCT) is back in focus after its PTC518 Huntington’s disease program received Fast Track designation, a regulatory milestone that can influence how investors view its rare neurology pipeline. See our latest analysis for PTC Therapeutics. At a share price of $78.59, PTC Therapeutics has a 90 day share price return of 8.67%, while its 1 year total shareholder return of 65% suggests stronger momentum over a longer window despite recent short term weakness. The Fast Track news...

Murphy USA Stock Snapshot After Recent Performance Murphy USA (MUSA) has drawn fresh attention after a strong recent run, with the stock up around 12% over the past month and about 25% over the past 3 months. See our latest analysis for Murphy USA. At a share price of $618.57, Murphy USA’s recent 1-day share price return of 3.27% and year to date share price return of 52.61% sit alongside a 1-year total shareholder return of 47.80% and 5-year total shareholder return of 341.46%. This points...

Concentra Group Holdings Parent recently opened a new medical center near Kansas City International Airport in Missouri, expanding access to occupational medicine, injury care, regulatory exams, and telemedicine-supported services for employers in a major Midwestern business and transportation hub. This expansion strengthens Concentra’s integrated network model by pairing on-site clinical capabilities with its Concentra Telemed platform, potentially enhancing employer convenience and...

In recent trading, First Bancorp (FBNC) saw a surge in options activity, with August 21, 2026 $70 call contracts exhibiting unusually high implied volatility and pointing to heightened speculation around the stock. This options-driven interest, combined with First Bancorp’s price-to-earnings ratio of 22.1x versus the broader US Banks industry, highlights how investors may be assigning a premium to its earnings profile despite mixed valuation signals. We’ll now examine how this spike in...

Recently, concerns surfaced after Intuitive Surgical cautioned that changes to certain U.S. insurance plans could slow procedure volumes, prompting a broad reassessment of demand for medical devices, including those made by Globus Medical. This development highlights how even indirect policy shifts in reimbursement can quickly ripple through procedure-dependent industries, challenging expectations for companies built around growing surgical technology adoption. Next, we’ll examine how...

In recent days, Mach Natural Resources has attracted increasingly positive analyst attention, including a Strong Buy consensus rating and fresh Buy recommendations from firms such as William Blair. This shift in analyst sentiment highlights growing institutional interest in Mach’s Anadarko-focused oil and gas model and its acquisition-led growth approach. Next, we’ll explore how this wave of bullish analyst coverage could influence Mach Natural Resources’ existing investment narrative and...

Enerpac Tool Group Corp. recently reported past third-quarter 2026 results showing year-over-year growth in sales to US$167.55 million and net income to US$29.8 million, while also completing a US$80.44 million buyback of 2,078,645 shares announced in October 2025. The company also slightly refined its full-year 2026 net sales outlook to a US$635 million–US$645 million range, highlighting management’s focus on calibrating expectations alongside improving earnings per share. We’ll now examine...

Earlier this month, regulators opened a Section 206 proceeding into PJM’s tariff rules for integrating large data-center loads, directly affecting New Era Energy & Digital’s data center and energy development plans in the region. By targeting how large, flexible and co-located loads pay for and access transmission upgrades, the review could materially influence New Era’s economics, grid access and long-term planning assumptions. We’ll now examine how PJM’s tariff review around integrating...

Kimbell Royalty Partners has delivered a 121.7% return over the past 5 years, yet its current valuation checks point to a stock that screens as overvalued on market multiples and only mixed on the broader metrics. That creates a clear tension for investors trying to weigh strong historical returns against what the current price implies. A 121.7% return over 5 years highlights that long term holders have already seen substantial gains, so the easy part of the rerating may be behind the...

Truist Financial (TFC) has put fresh numbers on the table for Q2 2026, reporting total revenue of US$4.9 billion and basic EPS of US$1.24, with trailing twelve month EPS at US$4.41 and net income of US$5.5 billion. These figures give investors a clear view of current earnings power. Over recent quarters, the company has reported revenue moving from US$4.4 billion in Q1 2025 to US$4.9 billion in Q2 2026, while quarterly EPS has ranged from US$0.88 to US$1.24. This release therefore represents...